| República da Coreia | Turquia | Áustria | |
| Terapêutica hormonal | de $2,000 | de $401 | de $7,000 |
| Terapia com Células Estaminais | de $716 | de $4,675 | de $8,500 |
| Resseção da vesícula biliar | de $5,800 | de $2,900 | de $9,000 |
| Aférese seletiva | - | de $1,550 | - |
A Bookimed não adiciona taxas extras aos preços de tratamento de Doença de Crohn. As tarifas vêm das listas oficiais de preços das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Doença de Crohn e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Doença de Crohn.
O Hospital Severance — o maior hospital multidisciplinar da Coreia do Sul. Foi o primeiro no país a receber a prestigiosa acreditação americana pela qualidade do tratamento — JCI.
A especialização do Severance — oncologia, check-up (exame de saúde), cirurgia da coluna, cirurgia cardíaca e oftalmologia.
As conquistas do hospital incluem a primeira cirurgia cardíaca robótica na Coreia e a primeira implantação na Ásia de um disco espinhal artificial na região cervical.
Anualmente, o Hospital Severance recebe para tratamento mais de 1 000 000 de pacientes internados, dos quais 30 000 são estrangeiros.
O Hospital Gangnam Severance é o maior hospital multidisciplinar de Seul, Coreia do Sul.
Especialização — oncologia, neurocirurgia, neurologia, cardiologia e check-up (exame abrangente).
A clínica foi uma das primeiras em Seul a obter a acreditação americana Joint Commission International. Isso confirma a conformidade com os padrões internacionais de segurança no tratamento e o uso de métodos modernos.
Entre as conquistas do centro médico — o primeiro transplante de pulmão na Coreia do Sul.
Dr. Cheon Won Seok is the Director of the Department of Gastroenterology at Naeun Hospital. His expertise includes gastrointestinal diseases; upper gastrointestinal endoscopy and colonoscopy; polypectomy; ESD (Endoscopic Submucosal Dissection); small-bowel capsule endoscopy; digestive disorders; gastric and esophageal cancer; Helicobacter pylori infection; liver diseases; and inflammatory bowel disease, including Crohn’s disease and ulcerative colitis.
He graduated from Kyung Hee University College of Medicine. He completed his internship at Kyung Hee Medical Center and his internal medicine residency at Hallym University Sacred Heart Hospital. He later served as a Clinical Instructor in Gastroenterology at Chung-Ang University Hospital. He is a full member of the Korean Association of Internal Medicine and a life member of the Korean Society of Gastrointestinal Endoscopy. He is also a board-certified subspecialist in gastrointestinal endoscopy and serves as a medical advisor to KBS, MBC, SBS, JTBC, and MBN.
Asan Medical Center is a top choice for Crohn’s disease. It hosts the first and largest specialized Inflammatory Bowel Disease center in Korea. This facility manages approximately 6,000 patients with Crohn's and ulcerative colitis. Other high-ranking Seoul-based hospitals like Severance Hospital and Seoul National University Hospital provide advanced multidisciplinary care.
Bookimed Expert Insight: While major university hospitals prioritize complex surgery, Korea's focus on digital systems offers a significant advantage for Crohn's management. Seoul National University Bundang Hospital uses the BESTcare system to prevent medical errors. This high-tech approach ensures precise tracking of long-term medication and lab results for chronic inflammatory conditions.
Patient Consensus: Patients note that major university hospitals are dependable for treating acute flares. However, travelers should bring a local referral and plan for a translator to navigate the complex administrative steps at these large centers.
South Korea routinely uses advanced diagnostic technologies and innovative therapies to manage Crohn's disease. Standard clinical protocols include high-definition capsule endoscopy, biologics, and hormone therapy. Leading medical centers in Seoul also offer emerging treatments like arterial stem cell therapy for complex inflammatory cases.
Bookimed Expert Insight: While many patients seek Korea for aesthetics, the country’s gastroenterology infrastructure is built on massive scale. Large facilities like Seoul National University Bundang Hospital serve over 1,500,000 patients annually and operate fully digitalized environments. This high volume allows doctors like Dr. Cheon Won Seok to maintain subspecialized expertise in inflammatory bowel disease, which is often managed within oncology-grade diagnostic centers rather than small private clinics.
Surgery for Crohn’s disease is becoming more common in Korea as incidence rates rise. Statistics show 60% to 80% of Korean patients require surgery eventually. Early intervention rates are 9.1% within five years of diagnosis. Minimally invasive laparoscopic techniques now account for up to 50% of these procedures.
Bookimed Expert Insight: Data from major Seoul centers shows a high concentration of complex cases. Asan Medical Center performs over 65,000 operations annually across all departments. Severance Hospital treats 1.6 million outpatients yearly and maintains JCI accreditation. Patients may prefer these high-volume facilities for their extensive experience with perianal complications.
Patient Consensus: Patients often worry about the high chance of recurrence after the first operation. Many note that choosing a specialist who uses laparoscopic methods makes recovery much easier.
South Korean centers manage Crohn-related fistulas using a multidisciplinary strategy focused on infection control and tissue healing. Specialized surgeons and gastroenterologists combine biologics with sphincter-sparing procedures like LIFT or stem cell therapy. These interventions aim to close tracts while fully preserving bowel continence.
Bookimed Expert Insight: South Korea is a pioneer in cellular medicine for Crohn's complications. Clinics like RE:YOUTH specialize in arterial delivery methods for stem cell therapy. This approach can be more effective than local injections. It delivers therapeutic cells through the blood supply directly to the inflamed perianal tissue.
Patient Consensus: Patients note that localized discussions on Korean treatment are rare in international circles. They emphasize the need to consult directly with Korean colorectal specialists who utilize advanced diagnostic tools like capsule endoscopy.